Top

Published in:

Open Access 01-06-2008 | Review

Impact of headache in Europe: a review for the Eurolight project

Authors: Lars Jacob Stovner, Colette Andrée, On behalf of the Eurolight Steering Committee

Published in: The Journal of Headache and Pain | Issue 3/2008

Abstract

A recent health economic survey in Europe has suggested that migraine is the costliest among the neurological disorders. According to many studies, migraine and other disorders lead to widespread suffering, reduction of quality of life, and marked impairment of participation, both in work and social activities. The present literature survey was made in order to summarize what is known on the subject, as a preparation for a EU-supported study to assess the impact in several EU countries with similar methodology and the same research instrument. Previous studies have yielded relatively reliable data only for migraine, whereas the impact of tension-type headache is virtually unknown or only very incompletely known for most dimensions of headache impact. Some data do suggest, however, that this headache may be as important from a health economic and a public health perspective as migraine. In future studies it is important to get population-based data from various countries relevant for estimation of indirect (mostly absenteeism from work and reduced working efficiency when having headache) and direct costs (related to medication, consultations, investigations and hospitalisations). Also, the impact on ability to get education and participate in the workforce is very relevant, as is the impact on love life and family planning. The quality of life of headache patients should be measured by validated instruments. To get a complete picture, one should also ask about the effect on the life of partners and children, and on the possible impact even when headache-free (e.g. fear of the next attack).

Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27:193–210PubMedCrossRef

Steiner TJ (2004) Lifting the burden: the global campaign against headache. Lancet Neurol 3:204–205PubMedCrossRef

Andlin-Sobocki P, Jönsson B, Wittchen HU, Olesen J (2005) Cost of disorders of the brain in Europe. Eur J Neurol 12:1–27PubMedCrossRef

Hagen K, Vatten L, Stovner LJ, Zwart JA, Krokstad S, Bovim G (2002) Low socio-economic status is associated with increased risk of frequent headache: a prospective study of 22718 adults in Norway. Cephalalgia 22:672–679PubMedCrossRef

Stewart WF, Lipton RB, Celentano DD, Reed ML (1992) Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 267:64–69PubMedCrossRef

Breslau N, Davis GC, Andreski P (1991) Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 37:11–23PubMedCrossRef

Rasmussen BK (1992) Migraine and tension-type headache in a general population: psychosocial factors. Int J Epidemiol 12:1138–1143CrossRef

Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, Lipton RB (2003) The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia 23:519–527PubMedCrossRef

Linde M, Dahlöf C (2004) Attitudes and burden of disease among self-considered migraineurs—a nation-wide population-based survey in Sweden. Cephalalgia 24:455–465PubMedCrossRef

10.

Gobel H, Petersen-Braun M, Soyka D (1994) The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia 14:97–106PubMedCrossRef

11.

Launer LJ, Terwindt GM, Ferrari MD (1999) The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 53:537–542PubMedCrossRef

12.

Stang P, Von Korff M, Galer BS (1998) Reduced labor force participation among primary care patients with headache. J Gen Intern Med 13:296–302PubMedCentralPubMedCrossRef

13.

Boardman HF, Thomas E, Croft PR, Millson DS (2003) Epidemiology of headache in an English district. Cephalalgia 23:129–137PubMedCrossRef

14.

Nikiforow R, Hokkanen E (1979) Effects of headache on working ability: a survey of an urban and a rural population in Northern Finland. Headache 19:214–218PubMedCrossRef

15.

Benassi G, D’Alessandro R, Lenzi PL, Manzaroli D, Baldrati A, Lugaresi E (1986) The economic burden of headache: an epidemiological study in the Republic of San Marino. Headache 26:457–459PubMedCrossRef

16.

Rasmussen BK, Jensen R, Olesen J (1992) Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Commun Health 42:443–446CrossRef

17.

Stovner LJ, Zwart JA, Hagen K, Terwindt G, Pascual J (2006) Epidemiology of headache in Europe. Eur J Neurol 13:333–345PubMedCrossRef

18.

Fiane I, Haugland M, Stovner L, Zwart JA, Bovim G, Hagen K (2006) Sick leave is related to frequencies of migraine and non-migrainous headache—the HUNT Study. Cephalalgia 26:960–967PubMedCrossRef

19.

Michel P, Dartigues JF, Duru G, Moreau J, Salamon R, Henry P (1999) Incremental absenteeism due to headaches in migraine: results from the Mig-Access French national cohort. Cephalalgia 19:503–510PubMedCrossRef

20.

Berg J (2004) Economic evidence in migraine and other headaches: a review. Eur J Health Econom 5:S43–S54CrossRef

21.

Pransky GS, Berndt E, Finkelstein SN, Verma S, Agrawal A (2005) Performance decrements resulting from illness in the workplace: the effect of headaches. J Occup Environ Med 47:34–40PubMed

22.

Michel P, Auray J, Chicoye A, Dartigues J, Lamure D, Duru G, Henry P, Salamon R (1993) Prise en charge des migraineux en France: Coût et recours aux soins. J Econ Med 11:71–80

23.

Auray JP (2006) Impact socio-economique de la migraine et des cephalees en France. CNS Drugs 20(Spec no.1):37–46PubMed

24.

Neubauer G, Uljaky R (2002) Migraine-a disease and its costs. Pharm Unserer Zeit 31:494–497PubMedCrossRef

25.

van Roijen L, Essink-Bot ML, Koopmanschap MA, Michel BC, Rutten FF (1995) Societal perspective on the burden of migraine in The Netherlands. Pharmacoeconomics 7:170–179PubMedCrossRef

26.

Lainez MJA, Monzon MJ (2003) The socioeconomic impact of migraine in Spain. In: Reducing the burden of headache. Oxford University Press, Oxford, pp 255–259

27.

Björk S, Roos P (1991) Economic aspects of migraine in Sweden. In: Working paper no 8 Institute for Health Economics, Lund. pp 5–24

28.

Blau N, Drummond M (1991) Migraine. Office of Health Economics, London, pp 26–30

29.

Cull R, Wells N (1992) The economic cost of migraine. Br J Med Econ 2:103–115

30.

Berg J, Stovner LJ (2005) Cost of migraine and other headaches in Europe. Eur J Neurol 12(Suppl 1):59–62PubMedCrossRef

31.

Rasmussen BK, Jensen R, Olesen J (1992) Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Commun Health 46:443–446CrossRef

32.

Boardman HF, Thomas E, Croft PR, Millson DS (2003) Epidemiology of headache in an English district. Cephalalgia 23:129–137PubMedCrossRef

33.

Badia X, Magaz S, Gutierrez L, Galvan J (2004) The burden of migraine in Spain: beyond direct costs. Pharmacoeconomics 22:591–603PubMedCrossRef

34.

Pradalier A, Auray JP, El Hasnaoui A, Alzahouri K, Dartigues JF, Duru G, Henry P, Lanteri-Minet M, Lucas C, Chazot G et al (2004) Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study. Pharmacoeconomics 22:985–999PubMedCrossRef

35.

Elston Lafata J, Moon C, Leotta C, Kolodner K, Poisson L, Lipton RB (2004) The medical care utilization and costs associated with migraine headache. J Gen Intern Med 19:1005–1012PubMedCrossRef

36.

Lucas C, Chaffaut C, Artaz MA, Lantéri-Minet M (2005) FRAMIG 2000: medical and therapeutic management of migraine in France. Cephalalgia 25:267–279PubMedCrossRef

37.

Lyngberg AC, Rasmussen BK, Jørgensen T, Jensen R (2005) Secular changes in health care utilization and work absence for migraine and tension-type headache: a population based study. Eur J Epidemiol 20:1007–1014PubMedCrossRef

38.

Dueland AN, Leira R, Burke TA, Hillyer EV, Bolge S (2004) The impact of migraine on work, family, and leisure among young women—a multinational study. Curr Med Res Opin 20:1595–1604PubMedCrossRef

39.

Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML (1999) Burden of migraine in the United States: disability and economic costs. Arch Intern Med 159:813–818PubMedCrossRef

40.

Dahlöf CG, Dimenäs E (1995) Migraine patients experience poorer subjective well-being/quality of life even between attacks. Cephalalgia 15:31–36PubMedCrossRef

41.

Hamelsky SW, Lipton RB, Stewart WF (2005) An assessment of the burden of migraine using the willingness to pay model. Cephalalgia 25:87–100PubMedCrossRef

42.

Morillo LE, Alarcon F, Aranaga N, Aulet S, Chapman E, Conterno L, Estevez E, Garcia-Pedroza F, Garrido J, Macias-Islas M et al (2005) Prevalence of migraine in Latin America. Headache 45:106–117PubMedCrossRef

43.

Steiner TJ (2005) Lifting the burden: the global campaign to reduce the burden of headache worldwide. J Headache Pain 6:373–377PubMedCentralPubMedCrossRef

44.

Leonardi M, Steiner TJ, Scher AT, Lipton RB (2005) The global burden of migraine: measuring disability in headache disorders with WHO’s Classification of Functioning, Disability and Health (ICF). J Headache Pain 6:429–440PubMedCentralPubMedCrossRef

45.

Olesen J, Leonardi M (2003) The burden of brain diseases in Europe. Eur J Neurol 10:471–477PubMedCrossRef

46.

Osterhaus JT, Townsend RJ, Gandek B, Ware JE (1994) Measuring the functional status and well-being of patients with migraine headache. Headache 34:337–343PubMedCrossRef

47.

Terwindt GM, Ferrari MD, Tijhuis M, Groenen SM, Picavet HS, Launer LJ (2000) The impact of migraine on quality of life in the general population: the GEM study. Neurology 55:624–629PubMedCrossRef

48.

Guitera V, Muñoz P, Castillo J, Pascual J (2002) Quality of life in chronic daily headache: a study in a general population. Neurology 58:1062–1065PubMedCrossRef

49.

Colás R, Muñoz P, Temprano R, Gómez C, Pascual J (2004) Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 62:1338–1342PubMedCrossRef

50.

Lipton RB, Liberman JN, Kolodner KB, Bigal ME, Dowson A, Stewart WF (2003) Migraine headache disability and health-related quality-of-life: a population-based case–control study from England. Cephalalgia 23:441–450PubMedCrossRef

51.

Bingefors K, Isacson D (2004) Epidemiology, co-morbidity, and impact on health-related quality of life of self-reported headache and musculoskeletal pain–a gender perspective. Eur J Pain 8:435–450PubMedCrossRef

52.

Michel P, Dartigues JF, Lindoulsi A, Henry P (1997) Loss of productivity and quality of life in migraine sufferers among French workers: results from the GAZEL cohort. Headache 37:71–78PubMedCrossRef

53.

Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF (2000) Migraine, quality of life, and depression: a population-based case-control study. Neurology 55:629–635PubMedCrossRef

54.

Duru G, Auray JP, Gaudin AF, Dartigues JF, Henry P, Lantéri-Minet M, Lucas C, Pradalier A, Chazot G, Hasnaoui AE (2004) Impact of headache on quality of life in a general population survey in France (GRIM2000 Study). Headache 44:571–580PubMedCrossRef

55.

Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF (2000) Migraine, quality of life, and depression: a population-based case-control study. Neurology 55:629–635PubMedCrossRef

56.

Kececi H, Dener S, Analan E (2003) Co-morbidity of migraine and major depression in the Turkish population. Cephalalgia 23:271–275PubMedCrossRef

57.

Zwart JA, Dyb G, Hagen K, Odegard KJ, Dahl AA, Bovim G, Stovner LJ (2003) Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Health Study. Eur J Neurol 20:147–152CrossRef

58.

Anttila P, Metsahonkala L, Mikkelsson M, Helenius H, Sillanpaa M (2001) Comorbidity of other pains in schoolchildren with migraine or nonmigrainous headache. J Pediatr 138:176–180PubMedCrossRef

59.

Hagen K, Einarsen C, Zwart JA, Svebak S, Bovim G (2002) The co-occurrence of headache and musculoskeletal symptoms amongst 51 050 adults in Norway. Eur J Neurol 9:527–533PubMedCrossRef

60.

Lipton RB, Bigal ME, Kolodner K, Stewart WF, Liberman JN, Steiner TJ (2003) The family impact of migraine: population-based studies in the USA and UK. Cephalalgia 23:429–440PubMedCrossRef

Title: Impact of headache in Europe: a review for the Eurolight project
Authors: Lars Jacob Stovner
Colette Andrée
On behalf of the Eurolight Steering Committee
Publication date: 01-06-2008
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 3/2008
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1007/s10194-008-0038-6

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Impact of headache in Europe: a review for the Eurolight project

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2008

Cluster-like headache and idiopathic intracranial hypertension: a case report

Topiramate in the prevention of pediatric migraine: literature review

Intracranial hemodynamics during intravenous infusion of glyceryl trinitrate

Similarities in stress physiology among patients with chronic pain and headache disorders: evidence for a common pathophysiological mechanism?

Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients

Epigenetics in primary headaches: a new avenue for research